Friday, October 30, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Novo Nordisk (NVO) Sets New 2030 Goals As GLP 1 Competition Builds

TR

By Tom Reyes · Markets Editor

Oct 30 13:09 ETSource: Yahoo Finance

From the source

Novo Nordisk (NVO) Sets New 2030 Goals As GLP 1 Competition Builds

Read at finance.yahoo.com

Source URL https://finance.yahoo.com/healthcare/articles/novo-nordisk-nvo-sets-2030-170922500.html

Prescribed peptides from $99/moSee all →